The share

Nexam Chemical Holding AB is listed on Nasdaq Stockholm First North Growth Market and the share is traded with the ticker NEXAM and ISIN-code SE0005101003.

The share capital amounts to SEK 1,5556,073.04, divided between 80,915,798 shares on only one class. All shares have a quotient value of SEK 1/52 and confer entitlement to one vote at the General Meeting.


Largest shareholders as of 30 September 2023

Shareholders* Number of shares Percentage
Insurance company, Avanza 8 407 546 10,4%
SIX SIS AG 7 035 690 8,7%
Svenolov Hjaelmstad 4 850 000 6,0%
Veronica Wallman 3 641 225 4,5%
Lennart Holm, privately and via company 2 074 426 2,6%
SEB Europa småbolag 1 889 797 2,3%
Nordnet Pensionsförsäkring AB 1 879 472 2,3%
The Bank of New York Mellon SA/NV 1 662 230 2,1%
Claes Mellgren 1 650 663 2,0%
Per Olof Andersson 1 615 664 2,0%
Other shareholders (approx. 5,500) 46 209 085 57,1%
Total 80 915 798 100,0%


*Nexam Chemicals ten largest owners according to the register of shareholders managed by Euroclear. For persons registered as insiders, the shareholder list includes the total holdings for the insider, including holdings which are held privately, through company and within the family.


Nexam Chemical follows, since July 3, 2016, article 19 in the Market Abuse Regulation (MAR).

According to MAR article 19, and the guidance from Finansinspektionen, managers and their closely associated shall report transactions to Finansinspektionen. Information about transactions in Nexam Chemicals share made by insiders are available at Finansinspektionens site.



Nasdaq Stockholm First North Growth Market

Nasdaq Stockholm First North Growth Market is an alternative market, operated by the different exchanges within Nasdaq. It does not have the same legal status as a regulated market. Companies at First North Growth Market are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. An investment in a company that is traded on First North Growth Market is riskier than an investment in a company that is traded on a regulated market.


Financial Calendar

Year-End Report 2023
Interim Report January-March 2024
Annual General Meeting 2024


Ronnie Törnqvist, CEO
+46 (0)706-25 41 85